$19.47▾ 0.36%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$5.04cash per $1 profit
Strong
It turns every reported profit-dollar into real cash, and then some.
Valuation
20th pctvs its own history
Cheap
Its valuation sits in the cheaper end of its own recent range.
Revenue growth
+4.0%year over year
Watch
Revenue growth has flattened.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Fairly valued
Trading right around our fair-value range
Value-trap risk
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
NRC Health turns 504¢ of every reported profit-dollar into real cash. Revenue growth has flattened. Its valuation sits in the cheaper end of its own recent range.
Key numbers
Valuation
EPS (TTM)$49.74
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin4.0%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$140.00M
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days29 articles
18 bullish11 neutral0 bearish
[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
AI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision Medicine
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?
VHT vs. PBE: Which Health Care ETF Is the Better Buy?
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.